Phase I study of PM00104 (Zalypsis®) administered as a...

Investigational New Drugs 2013 / 06 Vol. 31; Iss. 3

Phase I study of PM00104 (Zalypsis®) administered as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors

Massard, Christophe, Margetts, Jane, Amellal, Nadia, Drew, Yvette, Bahleda, Ratislav, Stevens, Peter, Armand, Jean Pierre, Calvert, Hilary, Soria, Jean Charles, Coronado, Cinthya, Kahatt, Carmen, Alfa
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-012-9843-5
Date:
June, 2013
File:
PDF, 171 KB
english, 2013
Conversion to is in progress
Conversion to is failed